Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Completed · Phase 1/Phase 2
Conditions studied: Lung Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I/II trial to compare the effectiveness of gemcitabine with radiation therapy alone or following two-drug combination chemotherapy in treating patients with stage III non-small cell lung cancer.
Key facts
- Study ID
- NCT00003202
- Run by
- Wake Forest University Health Sciences
- People needed
- 40
- Starts
- 1998-01-01
- Expected to finish
- 2006-07-01
- Last updated by the study team
- 2018-08-10
Who can join
Age: any, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Comprehensive Cancer Center at Wake Forest University — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.